Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

Researchers have unveiled new AI tools, from smartphone cough analysis to child-friendly screening systems, which could ...

An individual within the Aegis Living retirement community in Issaquah was diagnosed with active tuberculosis on Monday.

African scientists have developed a nanoscale drug delivery system to treat pericarditis, a drug-resistant and lethal ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

A new study published in PLOS Global Public Health contributes to the growing evidence that nutrition should be treated as a core part of tuberculosis care—not an afterthought. The research, conducted ...

An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

Background: Tuberculosis (TB) is a major contributor to the global burden of disease and has received considerable attention in recent years, particularly in low- and middle-income countries where it ...

I am writing to bring attention to a pressing issue that demands our collective action and support: The plight of those affected by tuberculosis (TB) and the critical need for enhanced treatment ...

The Food and Drug Administration approved a new tuberculosis medicine that shortens and improves treatment for the hardest-to-treat cases, a worsening problem in many poor countries. It's the first TB ...

Jiawan, D., Bansie, R., Chan, M., Thakoer, I. and Gopie, F.A. (2025) Necrotizing Sarcoid Granulomatosis with Concurrent ...